BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  BerGenBio ASA: Results for the First Quarter 2019

  BerGenBio ASA selective AXL kinase inhibitors for multiple cancer indications, announces its results for the first quarter 2019.

  May 8, 2019

   · 

  6 min read
• Deals

  Calliditas Therapeutics: Interim Report Q1, 2019

  This first quarter of 2019, we were busy ensuring that the recruitment efforts for our pivotal phase 3 study NefIgArd remain on track, focusing on site initiation visits and supporting our CRO in their work to ensure that all sites are brought online on a timely manner.

  May 8, 2019

   · 

  3 min read
• Drug Development

  BerGenBio Completes Recruitment Into Second Stage of Phase II Trial With Selective AXL inhibitor bemcentinib in Combination with KEYTRUDA® in Patients With Advanced NSCLC

  Phase II, Simon two-stage trial evaluating bemcentinib and KEYTRUDA in previously treated NSCLC post chemotherapy (Cohort A, NCT03184571)

  May 8, 2019

   · 

  5 min read
• Deals

  West Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences

  West Pharmaceutical Services, Inc. announced that the Company’s Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.

  May 8, 2019

   · 

  1 min read
• Biotech Beach

  ITT Veam and Cannon to Showcase Portfolio of High-Performance Rail Interconnect Solutions at Railtex 2019 in Birmingham, UK

  ITT to demonstrate its extensive rail connector expertise for both exterior and in-vehicle applications

  May 8, 2019

   · 

  3 min read
• Deals

  Vitamin Shoppe, Inc. Announces First Quarter 2019 Results

  Vitamin Shoppe, Inc. announced preliminary results for the three months ended March 30, 2019.

  May 8, 2019

   · 

  10 min read
• Deals

  Pfizer Acquires Clinical-Stage Biotech Therachon

  Expands Pfizer’s rare disease portfolio with potential first-in-class therapy for achondroplasia, a genetic condition and the most common form of short-limb dwarfism

  May 8, 2019

   · 

  8 min read
• Canadians urged to submit intervention to CRTC in support of described video

  Canadians who are blind were looking forward to described video for all shows during prime-time hours starting in September 2019, as mandated by the Canadian Radio-Television and Telecommunications Commission (CRTC).

  May 8, 2019

   · 

  4 min read
• Deals

  ReNeuron Provides Business Update and Results Notification

  Second Cohort of Phase 2a Study in Retinitis Pigmentosa Dosing Complete

  May 8, 2019

   · 

  6 min read
• Deals

  IFM Therapeutics and Novartis Complete Previously Announced Acquisition of IFM Tre

  IFM Therapeutics announced the completion of the previously-announced acquisition of its subsidiary, IFM Tre, by Novartis.

  May 8, 2019

   · 

  1 min read